Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Iacopo Petrini's publication output changed over time?
ScholarIQpublication output · 2009–2022
Output grew100% over the shown period — from 1 works in 2009 to 2 in 2022.
1
1
1
1
2
2
1
2
20092010201120122014201820192022
What are the most-cited papers on Iacopo Petrini?
ScholarIQmost cited works
PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
Fotios Loupakis, Luca Emanuele Pollina, I. Stasi, Annamaria Ruzzo, Mario Scartozzi, Daniele Santini, Gianluca Masi, Francesco Graziano, Chiara Cremolini, Eliana Rulli, Emanuele Canestrari, Niccola Funel, Gaia Schiavon, Iacopo Petrini, Mauro Magnani, Giuseppe Tonini, Daniela Campani, Irene Floriani, Stefano Cascinu, Alfredo Falcone
Journal of Clinical Oncology. 2009405 CitationsOPEN ACCESS
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors
Iacopo Petrini, Paul S. Meltzer, In‐Kyu Kim, Marco Lucchi, Kang-Seo Park, Gabriella Fontanini, James Gao, Paolo Andrea Zucali, Fiorella Calabrese, Adolfo Favaretto, Federico Rea, Jaime Rodriguez‐Canales, Robert L. Walker, Marbin Pineda, Yuelin J. Zhu, Christopher Lau, Keith Killian, Sven Bilke, Donna Voeller, Sivanesan Dakshanamurthy, Yisong Wang, Giuseppe Giaccone
S137905309. 2014260 CitationsOPEN ACCESS
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
Marzia Del Re, Riccardo Marconcini, G. Pasquini, Eleonora Rofi, Caterina Vivaldi, Francesco Bloise, Giuliana Restante, E. Arrigoni, Chiara Caparello, Maria Grazia Bianco, Stefania Crucitta, Iacopo Petrini, Enrico Vasile, Alfredo Falcone, Romano Danesi
British Journal of Cancer. 2018250 CitationsOPEN ACCESS
Thymic Malignancies: From Clinical Management to Targeted Therapies
Ronan J. Kelly, Iacopo Petrini, Arun Rajan, Yisong Wang, Giuseppe Giaccone
Journal of Clinical Oncology. 2011161 Citations
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer
Harvey R. Fernandez, Shreyas M. Gadre, Mingjun Tan, Garrett T. Graham, Rami Mosaoa, Martin S. Ongkeko, Kyu Ah Kim, Rebecca B. Riggins, Erika Parasido, Iacopo Petrini, Simone Pacini, Amrita K. Cheema, Rency S. Varghese, Habtom W. Ressom, Yuwen Zhang, Christopher Albanese, Aykut Üren, Mikell Paige, Giuseppe Giaccone, Maria Laura Avantaggiati
S152938505. 2018144 CitationsOPEN ACCESS
Related on ScholarIQ
University of Pisa
Institution
PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
Paper
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors
Paper
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
Paper
Thymic Malignancies: From Clinical Management to Targeted Therapies
Paper
The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer
Paper